Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivaroxaban Acute Stroke Safety Study

NCT02279940 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT02279940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02279940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivaroxaban Acute Stroke Safety Study
Lead sponsor
University of Alberta
Phase
Observational
Overall status
Completed
Start date
March 31, 2014
Completion date
Not reported
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, transient ischemic attack